<DOC>
	<DOCNO>NCT01486043</DOCNO>
	<brief_summary>The purpose study determine whether metformin effective adjunctive treatment transient hyperglycemia patient acute lymphoblastic leukemia ( ALL ) undergo induction chemotherapy</brief_summary>
	<brief_title>Metformin Transient Hyperglycemia</brief_title>
	<detailed_description>ALL common childhood cancer , represent one fourth cancer diagnose age 15 year . One common side effect ALL chemotherapy transient hyperglycemia . Patients develop complication require treatment insulin via injection prevent severe medical complication dehydration , weight loss , ketoacidosis life-threatening infection . Although insulin therapy effective , add lot physical psychological burden patient multiple daily insulin injection require achieve adequate blood glucose control . In pilot study , investigator aim examine effectiveness metformin adjunctive treatment transient hyperglycemia . Investigators compare two group subject ( 40 subject per group ) . Patients treatment group prospectively recruit , treat metformin addition insulin therapy . Investigators compare treatment group historical control group acquire via chart review . These patient treat insulin alone . Statistical comparison make two group term length insulin treatment , total daily dose insulin require , number insulin injection , hemoglobin A1c level ( measure glycemic control precede 8- 12 week ) , fructosamine level ( measure glycemic control precede 2-3 week ) . Investigators hypothesize use metformin result few number insulin injection few day insulin therapy .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>ALL patient induction chemotherapy develop transient hyperglycemia ( definition transient hyperglycemia : random blood glucose &gt; 200 mg/dL x 2 ) Adequate renal function ( serum Cr &lt; 1.5 mg/dL male , &lt; 1.2 mg/dL female ) Adequate hepatic function ( AST &lt; 5x upper limit normal ) Patients know diagnosis diabetes already oral hypoglycemic agent insulin Allergy metformin component formulation Patients pancreatitis ( lipase level &gt; 300 Units/L ) Patients active infection ( positive blood culture within 48 hour study registration ) Patients hemodynamic instability ( PICU status , need vasopressor within 48 hour study entry ) Elevated hemoglobin A1c ( great 6.0 % )</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Induction chemotherapy</keyword>
	<keyword>Transient hyperglycemia</keyword>
	<keyword>Metformin</keyword>
	<keyword>Acute lymphoblastic leukemia</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Hyperglycemia</keyword>
	<keyword>Insulin</keyword>
</DOC>